Presidents of GI Societies React to NYT Article

Presidents of GI Societies React to NYT Article

The GI community continues to react to The New York Times article on colonoscopy last week. Leaders of ASGE, ACG and AGA have communicated following the publication and have expressed a mutual commitment to clarifying for the public that colonoscopy is the best preventive test, its use has been lifesaving, it is generally considered cost effective, it is widely endorsed by the USPTF and American Cancer Society among others, and that it is recommended because it is in the best interests of our patients.  Each society immediately responded directly to the Times and we are exploring ways to work together longer term. Colonoscopy is one of gastroenterologists’ most valuable tools. Since 1998 when Medicare began covering colorectal cancer screening, we have together saved hundreds of thousands of lives through early detection and treatment of colorectal cancer.

Read response here.

Colon Cancer Screening tied to better outcomes

By Andrew M. Seaman

NEW YORK (Reuters Health) - People who are diagnosed with colon cancer after routine colonoscopies tend to have better outcomes and less advanced cancers than people diagnosed based on symptoms, says a new study.

Those who were diagnosed with colon cancer as a result of symptoms were three times more likely to die during the study than the patients diagnosed after colonoscopy screenings, researchers found.

"It's in line with its current use. It shows that colonoscopy appears to be beneficial in reducing deaths in those diagnosed with colorectal cancer," said Dr. Chyke Doubeni, who studies colonoscopy use but wasn't involved in the new research.

Colon cancer is the third most common cancer and the second leading cause of cancer death in the U.S., according to the government-backed U.S. Preventive Services Task Force (USPSTF), which recommends that people between ages 50 and 75 get screened by colonoscopy every ten years.

See full story here.

You are here Blog